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Purpose:  During  clinical  routine,  we  retrospectively  discovered  diagnostic  criteria  for  “focal  mastitis”  in
MR-Mammography  (MRM).  The  aim of  this  study  was  to prospectively  evaluate  these  criteria.
Methods:  1975  consecutive  patients  were  examined  between  01/2010  and  12/2011.  29 patients  ﬁt  the
diagnostic  criteria  of  focal  mastitis.
Results:  In follow-up  scans,  28 patients  showed  a  complete  remission  of  the  previous  ﬁndings.  One  patient
was  followed-up  with  persisting  ﬁndings,  which  could  histologically  be  correlated  to  an  area  of  DCIS after
biopsy.
Conclusion:  The  morphologic,  kinetic  and  follow-up  criteria  we discovered  seem  to  be a  reliable  diagnostic
indicator  for  focal  mastitis.
©  2016  The  Author(s).  Published  by  Elsevier  Ltd.  This  is  an open  access  article  under  the  CC  BY-NC-ND. Introduction
The role of MRI  as an imaging modality of the breast (MR-
ammography: MRM)  has evolved to be increasingly important
ver the last 20 years. So far current guidelines of the ACR list among
he speciﬁc indications for breast MR  mainly the following [1,2]:
) patients after operation or radiation
) preoperative staging
) cancer of unknown primary (CUP Syndrome)
) genetic disposition (BRCA1 or 2, etc.)
The increasing use of MR-mammography (MRM)  has ever since
een accompanied by the discussion about its appropriate tech-
ique and optimal accuracy, especially its speciﬁcity. For a long time
RM  has been attributed a high sensitivity, yet a low speciﬁcity.
The enhancement of a lesion strongly depends on the tumor
iology (benign vs. malignant), the type and dose of contrast as well
s the acquisition technique [3]. In order to reduce the number of
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false positive and false negative cases, more and more morpholog-
ical and kinetic signs have been evaluated in the past (including
e.g the Blooming sign, the Dark-T2w-TSE-Signal in the T2w-Turbo-
Spin Echo sequences, the Hook sign, the perifocal edema sign, etc.)
and need to be considered forming a diagnosis [4].
An additional ﬁnding in clinical routine over the last years was
patients displaying a focal, non-malignant, non-mass enhancement
in some areas, which had been included in the differential diagnosis
of DCIS and often resulted in a benign histology, mostly including
lymphocytic inﬁltration as a “side effect” (personal observations).
This report describes the ﬁnding of “MR-only-Mastitis”, in which
by use of follow-ups as reference standards and sometimes histol-
ogy an accompanying area of transitional focal enhancement was
discovered. These ﬁndings are described and the differential diag-
nostic aspects for the differentiation between mastitis and DCIS and
other malignant ﬁndings are listed.
2. Material and methods
All patients gave their written informed consent for the exam-
ination in this IRB approved study. As an additional indication we
included “dense breasts” to the list of general MRM indication in an
agreement with one of the major German insurance companies.
The ﬁrst patient to be discovered with focal mastitis was a
high-risk patient and had a history of two previous operations,
e under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/
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Fig. 1. From left to right: T2w TSE, subtractions 1, 2 and 7 min  post the injection of 0.1 mmol/kg contrast medium.
51-year old patient with ﬁbrocystic desease, presenting with a unilateral, patchy, non-focal area of benign enhancement in the outer aspect of the left breast in 11/2009 (blue
arrows). Upon inquiry the patient reported an otitis of the right ear 3 months prior to the scan. In a follow-up examination after 6 months (06/2010) the area of enhancement
could  no longer be detected. (For interpretation of the references to colour in this ﬁgure legend, the reader is referred to the web  version of this article.)
Fig. 2. From left to right: T2w TSE, subtractions 1, 2 and 7 min  post the injection of 0.1 mmol/kg contrast medium.
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n  the close history. In a follow-up examination after 12 months (07/2008) the ﬁn
04/2011). (For interpretation of the references to colour in this ﬁgure legend, the r
espectively 26 and 19 years before. In a follow-up study this
atient displayed an area of focal enhancement with diffuse borders
nd continuously rising, benign curves. By chance we  discovered
hat the patient also suffered from conjunctivitis of the eye at the
ame time. Due to the high-risk circumstances of this patient, she
as followed-up on 4 weeks later (same time in her menstrual
ycle) and by that time her conjunctivitis had declined. In the re-
xamination the focal area of enhancement had disappeared; the
dea came up, that an inﬂammation in other areas of the body
part from the breast (ear, throat, bronchitis, arthritis, etc.) could beement in the right breast in 05/2007 (blue arrows). The patient reported a laryngitis
had dissolved completely and did not reappear in further follow-up examinations
is referred to the web  version of this article.)
responsible for transitional, focal, non-mass areas of enhancement
in the breast. As this sign was further seen in a continuous number
of 5 other patients, we  conducted a prospective study in order to
evaluate focal mastitis as a new sign.
Our ﬁnding is ”accidental” and does not describe clinically man-
ifest “classical” mastitis of the breast (reddish coloring of the skin
in one breast, painful palpation, abscess etc.).Summarizing, the study was retrospective for 5 patients in order
to study early effects as well as morphology and kinetics of focal
mastitis and prospective for a total of 29 patients between 01/2010
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Fig. 3. From left to right: T2w TSE, subtractions 1, 2 and 7 min  post the injection of 0.1 mmol/kg contrast medium.
55-year old patient with ﬁbrocystic desease, presenting with two small unilateral, patchy, non-focal areas of enhancement in the right breast in 06/2006 (blue arrows). Upon
ininquiry, the patient reported she had suffered from viral respiratory tract infection (common ﬂew) a few weeks before the MR-mammogram. In a follow-up examination
after  3 months (09/2006) the ﬁndings had dissolved completely and did not reappear in further follow-up examinations (09/2009 and 09/2011). (For interpretation of the
references to colour in this ﬁgure legend, the reader is referred to the web version of this article.)
Table 1
Examination protocol.
Sequence (Nr.) 1. Nat cor 2. Dynamica tra 3. CM cor 4. T2-TSE 5. STIR
Weighting T1 T1 T1 T2 T2 (T1, 150 ms)
Puls  sequence FLASH FLASH FLASH TSE TSE
Orientation cor transv cor transv transv
TR  (ms) 113 113 113 8900 8420
TE  (ms) 4,6 4,6 4,6 207 70
Flip  angle (◦) 80 80 80 191 180
Slice  thickness (mm)  3 3 3 3 3
Gap  (mm)  0 0 0 0 0
Field  of view (mm)  350 350 350 350 350
Nr.  of slices 44 44 44 44 44
Matrix  (Pixels) 230 × 256 307 × 384 230 × 256 435 × 512 326 × 384
d-DTP
a
a
c
1
2a Connotation: dynamic study before and after the i.v. application of 0,1 mmol  G
utomatic injector (Medrad, Spectris, Pittsburgh) with 3 ml/s .
nd 12/2011. These patients would usually not have a history of
linical mastitis, yet displayed the following ﬁndings:
. A slight, focal, unilateral non-mass and area of progredient
enhancement without cancer corner or washout sign (see
Figs. 1–6).
. When inquired about a recent history of inﬂammation or infec-
tion, patients would report about otitis, arthritis, sinusitis,
inﬂammatory processes of the skin, etc.A per kg body weight within 10 s, followed by the injection of 30 ml saline via an
3. They would also describe a subtle discomfort they had registered
in the affected breast upon forceful palpation.
4. Dissolving or at least decline after a waiting period of at least 3
months.Since serological parameters (CRP) occurred to be unspeciﬁc
in the retrospectively analyzed patients, CRP was therefore not
included into the evaluation of the prospective study cases.
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Fig. 4. From left to right: T2w TSE, subtractions 1, 2 and 7 min  post the injection of 0.1 mmol/kg contrast medium.
44-year old patient with ﬁbrocystic desease, presenting with a large unilateral, patchy, non-focal area of enhancement in the right breast in April 2010 (blue arrows) after an
inconspicuous MR-mammogram in 06/2007. Upon ininquiry, the patient reported she had suffered from a Hordeolum of the right eye two  months prior to the examination.
In  a follow-up examination after 4 months (08/2010) the ﬁndings were regredient. In a further follow-up after 14 months (12/2011), the previous ﬁndings had dissolved.
(For  interpretation of the references to colour in this ﬁgure legend, the reader is referred to the web version of this article.)
Fig. 5. From left to right: T2w TSE, subtractions 1, 2 and 7 min  post the injection of 0.1 mmol/kg contrast medium.
44-year old patient, presenting with two areas of unilateral, patchy, benign enhancement in the lower aspects of the right breast in 05/2011 (blue arrows). With a patient
history  of tonsillitis 2 months prior to the MR-Mammogram, a follow-up examination after 6 months in 11/2011 was conducted. See Fig. 6 for a magniﬁcation of the right
breast. (For interpretation of the references to colour in this ﬁgure legend, the reader is referred to the web  version of this article.)
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Fig. 6. Magniﬁcation of the right breast (Fig. 5). From left to right: T2w TSE, subtractions 1, 2 and 7 min  post the injection of 0.1 mmol/kg contrast medium.
44-year old patient, presenting with two areas of unilateral, patchy, benign enhancement in the lower aspects of the right breast in 05/2011 (blue arrows). With a patient
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The standard reference was a follow-up MRM-evaluation after
 waiting period of 3–6 months: these diagnostic focal, non-mass
reas of enhancements as well the discomfort during palpation
issolved or declined in the follow-up MRM  examination after
uccessful treatment or self-healing of the reported inﬂammatory
rocess. In case of these MRM  ﬁndings a “focal mastitis” was diag-
osed (Fig. 1). In none of the cases of this study an accompanying
nﬂammatory cancer was found; no patient showed an increase (1
ase of consistent enhancement) of either the MRM-  or the clinical
ymptoms.
.1. MR-Scanner
All MRM  exams were performed with a 1.5 T-MR Scanner
Siemens, Avanto) using the following standard protocol (Table 1),
s described in other publications [5].
. Results
Between 07/2010 and 12/2011, 1975 breast patients have
een examined in our University Hospital. Among these 1975
atients the total amount of 29 patients showed signs of a distinct
ocal mastitis (unilateral enhancement, progredient enhancement,
atchy-conﬂuent enhancement, no corner sign, reversible after
ntibiotic treatment or waiting period, slight unilateral discom-
ort during forceful palpation). These patients were recommended
RM  follow-up examination after 6 months in order to evaluate,
hether or not the “lesion” had dissolved. In the follow-up the
ollowing results were received.
28 patients showed a complete or nearly complete dissolving of
he previous ﬁndings. 1 patient was found to display a progredi-
nt area of enhancement, which histologically proved to be a small
ocus of DCIS after biopsy.
. DiscussionMRM  is a highly sensitive technique to detect changes in the
reast, induced by vascularization. Among these changes are malig-
ant lesions, but also changed vascularization due to inﬂammatory
rocesses. To our knowledge, this study was the ﬁrst to describe thisr 6 months in 11/2011 was conducted. The larger area of enhancement in the outer
 of the right breast stayed constant in morphology and kinetics. (For interpretation
of this article.)
accompanying phenomenon, which are slight and distinct, but have
to be considered in the differential diagnosis of non-mass lesions.
In the literature the morphological and kinetic signs of non-
puerperal mastitis have been known for some time, however most
of these reports have been severe granulomatous mastitis-cases
and abscesses [6]. As a hallmark of “focal transitional mastitis”,
we assessed a unilateral area of slight, non-mass and continu-
ous enhancement without border sign (i.e. no separation between
segments of the breast − an indication of DCIS), an inﬂamma-
tory anamnesis as well as slight discomfort upon palpation of the
affected breast in contrast to the contralateral breast; in addition,
the patient had reported about an infection in other parts of the
body upon questioning. Since this type of enhancement appeared
to dissolve in follow-up studies it was  considered the result of focal
inﬂammation.
In our experience accompanying hormone- or menstrual effects
are furthermore unlikely to cause such enhancement, as they rather
tend to affect both breasts and therefore are not relevant for the
differential diagnosis of lesions imaged with our technique.
The detection of focal transitional mastitis in MR-
Mammography is probably only possible due to the very high
contrast and sensitivity towards changes after contrast injection of
the MR-technique. It is also an example how a medical diagnosis is
made by a combination of imaging ﬁndings, clinical examination,
the evaluation of the patients history and results of follow-up
examinations. Only when these effects are not regredient in
follow-up examinations, a biopsy should be recommended to test
for a malignant ﬁnding. The knowledge of this diagnosis (focal
transitional mastitis) seems to be important in order to reduce the
number of unnecessary biopsies in the future.
5. Conclusion
Among the differential diagnosis of enhancing breast lesions, a
focal area of transitional inﬂammation needs to be added to the
list of differential diagnosis. Typical signs are: continuous unilat-
eral enhancement, lack of border signs, inﬂammatory anamnesis,
accompanying discomfort upon palpation of the affected breast.
The patient should be followed-up on for correlation of focal inﬂam-
mation after a time period of not longer than 6 months (eventually
applying antibiotic treatment), in order to rule out DCIS or a
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